HI-B9

N/A

Report date: 2025/06/11 11:01:28
NME

Base Information

Drug NameHI-B9
Drug Alias Namebeta-catenin/TCF4 interaction inhibitor (University of Minnesota)HI-B1HI-B9
ClassificationSmall molecules
Mechanisms of ActionCatenin beta 1 degraders
TargetsCatenin beta 1
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Minnesota
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Minnesota
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A